ACLARION, INC. Operating Income
ACLARION, INC. (ACON) reported Operating Income of -$2.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- ACLARION, INC. operating income (loss) for the quarter ending 2026-06-30 was -$2.90M.
- ACLARION, INC. operating income (loss) for the quarter ending 2026-03-31 was -$2.99M.
- ACLARION, INC. operating income (loss) for the quarter ending 2025-12-31 was -$1.99M.
- ACLARION, INC. operating income (loss) for the quarter ending 2025-09-30 was -$1.83M.
- ACLARION, INC. operating income (loss) for fiscal 2025 was -$7.05M.
- ACLARION, INC. operating income (loss) for fiscal 2024 was -$5.51M.
- ACLARION, INC. operating income (loss) for fiscal 2023 was -$4.88M.
- ACLARION, INC. operating income (loss) for fiscal 2022 was -$5.56M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.90M 10-Q · filed 2026-08-06 | -$5.89M 10-Q · filed 2026-08-06 | -$7.88M derived: sum of 3 quarters · filed 2026-08-06 | -$9.71M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$2.99M 10-Q · filed 2026-05-13 | -$4.98M derived: sum of 2 quarters · filed 2026-05-13 | -$6.81M derived: sum of 3 quarters · filed 2026-05-13 | -$8.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$3.82M derived: sum of 2 quarters · filed 2026-03-18 | -$5.56M derived: sum of 3 quarters · filed 2026-08-06 | -$7.05M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | -$1.83M 10-Q · filed 2025-11-12 | -$3.57M derived: sum of 2 quarters · filed 2026-08-06 | -$5.06M 10-Q · filed 2025-11-12 | -$6.87M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$1.74M 10-Q · filed 2026-08-06 | -$3.23M 10-Q · filed 2026-08-06 | -$5.03M derived: sum of 3 quarters · filed 2026-08-06 | -$6.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$1.49M 10-Q · filed 2026-05-13 | -$3.30M derived: sum of 2 quarters · filed 2026-05-13 | -$4.59M derived: sum of 3 quarters · filed 2026-05-13 | -$5.73M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$3.10M derived: sum of 2 quarters · filed 2026-03-18 | -$4.24M derived: sum of 3 quarters · filed 2026-03-18 | -$5.51M 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | -$1.30M 10-Q · filed 2025-11-12 | -$2.43M derived: sum of 2 quarters · filed 2025-11-12 | -$3.71M 10-Q · filed 2025-11-12 | -$4.83M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$1.14M 10-Q · filed 2025-08-14 | -$2.41M 10-Q · filed 2025-08-14 | -$3.54M derived: sum of 3 quarters · filed 2025-08-14 | -$4.70M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$1.28M 10-Q · filed 2025-05-15 | -$2.40M derived: sum of 2 quarters · filed 2025-05-15 | -$3.56M derived: sum of 3 quarters · filed 2025-05-15 | -$4.97M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | -$2.29M derived: sum of 2 quarters · filed 2025-04-09 | -$3.69M derived: sum of 3 quarters · filed 2025-04-09 | -$4.88M 10-K · filed 2025-04-09 | ||||
| 2023-09-30 | -$1.16M 10-Q · filed 2024-11-14 | -$2.57M derived: sum of 2 quarters · filed 2024-11-14 | -$3.75M 10-Q · filed 2024-11-14 | -$4.69M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$1.41M 10-Q · filed 2024-08-14 | -$2.59M 10-Q · filed 2024-08-14 | -$3.53M derived: sum of 3 quarters · filed 2024-08-14 | -$5.16M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$1.18M 10-Q · filed 2024-05-15 | -$2.12M derived: sum of 2 quarters · filed 2024-05-15 | -$3.76M derived: sum of 3 quarters · filed 2024-05-15 | -$5.97M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$942.46K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$2.58M derived: sum of 2 quarters · filed 2024-03-28 | -$4.79M derived: sum of 3 quarters · filed 2024-03-28 | -$5.56M 10-K · filed 2024-03-28 | -$6.10M 10-K · filed 2023-02-27 | |||
| 2022-09-30 | -$1.63M 10-Q · filed 2023-11-14 | -$3.85M derived: sum of 2 quarters · filed 2023-11-14 | -$4.62M 10-Q · filed 2023-11-14 | -$4.77M 10-Q · filed 2022-11-14 | -$5.69M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$2.21M 10-Q · filed 2023-08-25 | -$2.37M 10-Q · filed 2022-08-15 | -$2.99M 10-Q · filed 2023-08-25 | -$3.14M 10-Q · filed 2022-08-15 | -$4.05M derived: sum of 3 quarters · filed 2023-08-25 | -$4.85M derived: sum of 4 quarters · filed 2023-08-25 | ||
| 2022-03-31 | -$773.10K 10-Q · filed 2023-07-03 | -$1.84M derived: sum of 2 quarters · filed 2023-07-03 | -$2.64M derived: sum of 3 quarters · filed 2023-07-03 | -$3.27M derived: sum of 4 quarters · filed 2023-07-03 | ||||
| 2021-12-31 | -$1.07M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | -$1.87M derived: sum of 2 quarters · filed 2023-06-12 | -$2.49M derived: sum of 3 quarters · filed 2023-06-12 | -$2.95M 10-K/A · filed 2023-06-12 | ||||
| 2021-09-30 | -$797.25K 10-Q · filed 2022-11-14 | -$1.42M derived: sum of 2 quarters · filed 2022-11-14 | -$1.88M 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$626.62K 10-Q · filed 2022-08-15 | -$1.09M 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$460.54K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |